A passive hemagglutination test for leprosy using a synthetic disaccharide antigen

Area of Science:

• Immunology
• Tropical Medicine
• Diagnostic Development

Background:

• Leprosy diagnosis requires simple, sensitive, and specific serological tests.
• Existing diagnostic methods may lack the necessary sensitivity or specificity for widespread use.

Purpose of the Study:

• To develop and evaluate a novel passive hemagglutination (PHA) test for the serodiagnosis of leprosy.
• To assess the sensitivity and specificity of the PHA test using a synthetic antigen.

Main Methods:

• A synthetic disaccharide specific for Mycobacterium leprae was conjugated to bovine serum albumin.
• The conjugate was sensitized to sheep erythrocytes for a passive hemagglutination assay.
• Sera from leprosy patients, tuberculosis patients, and healthy controls were tested at dilutions of 1:64 and 1:128.

Main Results:

• At a 1:128 dilution cutoff, the PHA test detected 84.2% of multibacillary leprosy cases.
• The test showed lower positivity rates in paucibacillary leprosy (16.7%) and tuberculosis (11.8%).
• The PHA test demonstrated high sensitivity and moderate specificity, comparable to ELISA for IgM antibodies.

Conclusions:

• The developed passive hemagglutination test is a simple and sensitive method for leprosy serodiagnosis.
• Its characteristics make it highly suitable for large-scale screening of contacts in leprosy-endemic regions.
• Further validation may be needed to enhance specificity for broader clinical application.